Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2005 Dec 9;35(2):142–149. doi: 10.1002/jmv.1890350213

Modulation of coronavirus‐mediated cell fusion by homeostatic control of cholesterol and fatty acid metabolism

Marguerite Cervin 1, Robert Anderson 1,
PMCID: PMC7159151  PMID: 1662706

The content is available as a PDF (795.5 KB).

References

  1. Allison AC (1974): On the role of mononuclear phagocytes in immunity against viruses. Progress in Medical Virology 18: 15. [PubMed] [Google Scholar]
  2. Arnheiter H, Baechi T, Haller O (1982): Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3. Journal of Immunology 129: 1275–1281. [PubMed] [Google Scholar]
  3. Asano K, Asano A (1988): Binding of cholesterol and inhibitory peptide derivatives with the fusogenic hydrophobic sequence of F‐glycoprotein of HVJ (Sendai virus): Possible implication in the fusion reaction. Biochemistry 27: 1321–1329. [DOI] [PubMed] [Google Scholar]
  4. Campbell AE, Loria RM, Madge GE, Kaplan AM (1982): Dietary hepatic cholesterol elevation: Effects on coxsackie B infection and inflammation. Infection and Immunity 37: 307–317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daya M, Cervin M, Anderson R (1988): Cholesterol enhances mouse hepatitis virus‐mediated cell fusion. Virology 163: 276–283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Daya M, Wong F, Cervin M, Evans G, Vennema H, Spaan W, Anderson R (1989): Mutation of host cell determinants which discriminate between lytic and persistent mouse hepatitis virus infection results in a fusion‐resistant phenotype. Journal of General Virology 70: 3335–3346. [DOI] [PubMed] [Google Scholar]
  7. Demel RA, Geurts van Kessel WSM, van Deenen LLM (1972): The properties of polyunsaturated lecithins in monolayers and liposomes and the interaction of those lecithins with cholesterol. Biochimica et Biophysica Acta 266: 26–40. [DOI] [PubMed] [Google Scholar]
  8. Fillios LC, Andrus SB, Mann GV, Stare FJ (1956): Experimental production of gross atherosclerosis in the rat. Journal of Experimental Medicine 104: 539–554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Frank JS, Fogelman AM (1989): Ultrastructure of the intima in WHHL and cholesterol‐fed rabbit aortas prepared by ultra‐rapid freezing and freeze‐etching. Journal of Lipid Research 30: 967–973. [PubMed] [Google Scholar]
  10. Garg L, Sabine JR (1988): Homoeostatic control of membrane cholesterol and fatty acid metabolism in the rat liver. Biochemical Journal 251: 11–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Johnson MK, Geoffroy C, Alouf JE (1980): Binding of cholesterol by sulfhydryl‐activated cytolysins. Infection and Immunity 27: 97–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kos WL, Loria RM, Snodgrass MJ, Cohen D, Thorpe TG, Kaplan AM (1979): Inhibition of host resistance by nutritional hypercholesteremia. Infection and Immunity 26: 658–667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kos WL, Kos KA, Kaplan AM (1984): Impaired function of immune reactivity to Listeria monocytogenes in diet‐fed mice. Infection and Immunity 43: 1094–1096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Loria RM, Kibrick S, Madge GE (1976): Infection of hypercholesterolemic mice with coxsackie B. Journal of Infectious Diseases 133: 655–662. [DOI] [PubMed] [Google Scholar]
  15. Manaker RA, Piczak CV, Miller AA, Stanton MF (1961): A hepatitis virus complicating studies with mouse leukemia. Journal of the National Cancer Institute 27: 29–44. [PubMed] [Google Scholar]
  16. McMurchie EJ (1988): Dietary lipids and the regulation of membrane fluidity and function In: “Physiological Regulation of Membrane Fluidity,” Chapter 7 New York: Alan R. Liss, pp 189–237. [Google Scholar]
  17. Mims CA (1964): Aspects of the pathogenesis of virus diseases. Bacteriological Reviews 28: 30–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mizzen L, Cheley S, Rao M, Wolf R, Anderson R (1983): Fusion resistance and decreased infectability as major host cell determinants of corona virus persistence. Virology 128: 407–417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pereira CA, Steffan AM, Koehren F, Douglas CR, Kirn A (1987): Increased susceptibility of mice to MHV‐3 infection induced by hypercholesterolemic diet: Impairment of kupffer cell function. Immunobiology 174: 253–265. [DOI] [PubMed] [Google Scholar]
  20. Roos DS, Duchale CS, Stephensen CB, Holmes KV, Choppin PW (1990): Control of virus‐induced cell fusion by host cell lipid composition. Virology 175: 345–357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rothfels KH, Axelrad AA, Siminovitch L, McCulloch EA, Parker RC (1959): The origin of altered cell lines from mouse, monkey and man as indicated by chromosome and transplantation studies. Canadian Cancer Conference 3: 189–214. [Google Scholar]
  22. Ruebner BH, Bramhall JL, Berry GR (1958): Experimental virus hepatitis in choline‐deficient mice with fatty livers. Archives of Pathology and Laboratory Medicine 66: 165. [PubMed] [Google Scholar]
  23. Ruebner BH, Bramhall JL (1960): The effect of changes in dietary protein on experimental viral hepatitis in mice. Gastroenterology 39: 335. [PubMed] [Google Scholar]
  24. Sabesin SM, Koft RS (1974): Pathogenesis of experimental viral hepatitis. New England Journal of Medicine 290: 944–950. [DOI] [PubMed] [Google Scholar]
  25. Smith MS, Click RE, Plagemann RGW (1984): Control of mouse hepatitis virus replication in macrophages by a recessive gene on chromosome 7. Journal of Immunology 133: 428–432. [PubMed] [Google Scholar]
  26. Virelizier JL, Allison AC (1976): Correlation of persistent mouse hepatitis (MHV‐3) infection with its effects on mouse macrophage cultures. Archives of Virology 50: 279–285. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Virology are provided here courtesy of Wiley

RESOURCES